A Study to Evaluate the Efficacy and Safety of HRS-4729 Injection in Obesity

Clinical trial NCT07690826 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07690826
Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Overweight or Obesity

Start date: 2026-07-01
Primary completion: 2027-03-01
Enrollment: 252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.